NWB Finland Oy to Showcase AINA Natural Water's Bag-in-Box Packaging at ECRM 2026
NWB Finland Oy will present its AINA Natural Water in 5-liter and 10-liter bag-in-box formats at the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, offering retailers a premium water...
Rising Uninsured Rates Threaten Health Coverage for All Americans
As health insurance premiums climb and recent legislative changes take effect, a growing number of Americans are becoming uninsured or underinsured, with broad implications for the entire healthcare s...
TNT Targets U.S. Retail Expansion at ECRM Sports Nutrition Session
German sports nutrition brand TNT will attend the ECRM Vitamin, Weight Management & Sports Nutrition Session to build retail relationships and accelerate its U.S. expansion.
Dental Design Studios Expands Full Arch Implants and Emergency Care to Nine Phoenix Offices
Dental Design Studios has expanded its cosmetic, implant, and emergency dental services across nine Phoenix-area locations, improving access to full arch implants, smile makeovers, and same-day urgent...
Earth Science Tech's Integrated Healthcare Platform Drives 7.9% Revenue Growth and Debt Reduction
Earth Science Tech Inc. reported fiscal 2026 revenue of $35.7 million, up 7.9% year-over-year, while eliminating long-term debt and strengthening its balance sheet, positioning the company for continu...
SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program with SSi Mantra 3.0
SS Innovations International has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, marking a significant step in expanding robotic-assisted cardiac care and highlig...
Optimi Health Plans Phase 2 Psilocybin Trial for Major Depressive Disorder
Optimi Health Corp. announced plans for a multisite Phase 2 clinical trial of psilocybin-assisted therapy for major depressive disorder, set to begin in the first half of 2027.
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, is advancing to a Phase 2 trial for multiple sclerosis after FDA clearance of its IND application, with potential to address...
SS Innovations Reports 79% Growth in SSi Mantra Procedures Amid Global Expansion
SS Innovations International announced a 79% increase in SSi Mantra surgical procedures and a 42% expansion of its installed base, signaling growing global adoption of affordable robotic surgery.
Helus Pharma CEO to Present at Morgan Stanley Global Healthcare Conference
Helus Pharma CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference, highlighting the company's progress in developing novel treatments...
Onco-Innovations CMO Highlights ONC010's Dual Selectivity in BioMedWire Podcast
Onco-Innovations' CMO discusses the company's lead drug candidate ONC010, which targets the DNA repair enzyme PNKP with two selectivity mechanisms, and its planned first-in-human clinical program.
Visory Health Named to Fast Company's 2026 Best Workplaces for Innovators List
Visory Health's inclusion on Fast Company's 2026 Best Workplaces for Innovators list highlights its innovative workplace culture that drives its mission to make prescriptions affordable for millions o...
New Stroke Rehabilitation Guideline Emphasizes Early, Personalized, and Lifelong Recovery
The American Stroke Association's 2026 Guideline for Adult Stroke Rehabilitation and Recovery highlights the importance of starting rehab within 48 hours and tailoring care to individual needs, offeri...
Earth Science Tech Builds Self-Sustaining Healthcare Conglomerate Through Vertical Integration
Earth Science Tech Inc. (ETST) leverages vertical integration and dual-segment targeting to create a self-sustaining healthcare business, positioning itself for long-term growth.
Kairos Pharma CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference
Kairos Pharma's CEO will present at a major investment conference, highlighting its lead candidate ENV-105 designed to overcome cancer drug resistance.
Expert Warns of Hidden Crisis in UTI Diagnosis, Highlighting Need for Advanced Testing
An expert flags a hidden crisis in how UTIs are diagnosed, emphasizing the need for more accurate testing to address recurrent infections and their impact on women's lives.
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting SPC-15 Progress
Silo Pharma's participation in the IPAC-RS 2026 Nasal Innovation Forum underscores its commitment to advancing SPC-15, a nose-to-brain PTSD treatment, with promising stability data.
Quantum BioPharma's Lucid-MS Clears FDA Phase 2 Milestone, Offering New Hope for Multiple Sclerosis Treatment
Quantum BioPharma's Lucid-MS has received FDA clearance for a Phase 2 trial, marking a significant step toward a first-in-class therapy that may protect and repair myelin in multiple sclerosis patient...
GeoVax Welcomes Global Mpox Vaccine Stockpile Launch, Emphasizes GEO-MVA's Role in Diversifying Supply
GeoVax supports the new global mpox vaccine stockpile initiative and highlights its GEO-MVA candidate's readiness to strengthen supply resilience and equitable access.
ORGANA International Brings Nearly Three Decades of Natural Wellness Experience to ECRM
ORGANA International, a natural wellness company founded in 1997, will attend ECRM to expand its retail presence, leveraging its diverse product portfolio and consumer education approach.
Translational Longevity Takes Center Stage in August Wellness Index Report
The August Wellness Index Report spotlights translational longevity—the crucial work of moving scientific breakthroughs from lab to patient—ahead of the Translational Longevity Summit in Boston.
Retail Veteran Mitch Gould Brings Decades of Experience to ECRM Session
Mitch Gould, CEO of Nutritional Products International, will leverage his extensive retail background at the upcoming ECRM Vitamin, Weight Management & Sports Nutrition Session to forge valuable retai...
Nano-X Imaging Expands Nanox.ARC Distribution to New England Through New Partnership
Nano-X Imaging's new distribution agreement with Associated X-Ray Imaging Corp. aims to increase access to its FDA-cleared Nanox.ARC 3D tomosynthesis system in outpatient and community care settings a...
Laser Therapy Emerges as Promising Brain Cancer Treatment, Study Finds
Researchers at Washington University School of Medicine have advanced laser interstitial thermal therapy (LITT) as a less invasive alternative to surgery, potentially improving outcomes for brain canc...
Quantum BioPharma Receives FDA Clearance for Phase 2 Trial of Lucid-MS in Multiple Sclerosis
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials for MS marks a pivotal step in developing a targeted therapy that may offer a new approach to treating the disease, with poten...
Quantum BioPharma's Lucid-MS Gains FDA Clearance for Phase 2 Multiple Sclerosis Trial
Quantum BioPharma has received FDA clearance to begin a Phase 2 trial of its investigational multiple sclerosis drug Lucid-MS, a potential first-in-class treatment that targets demyelination rather th...
Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer Amid TONMYA Launch
Tonix Pharmaceuticals has promoted Thomas Englese to Chief Commercial Officer, underscoring the company's focus on expanding the commercial reach of its fibromyalgia treatment TONMYA.
Synbio International Licenses Proprietary Nutraceuticals to Accelerate Revenue
Synbio International has entered an exclusive licensing agreement with MD PHD Wellness to commercialize proprietary nutraceutical products, marking a strategic move to generate near-term revenue while...